These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1361666)

  • 1. Protein kinase C and dopamine transport--2. Effects of amphetamine in vitro.
    Giambalvo CT
    Neuropharmacology; 1992 Dec; 31(12):1211-22. PubMed ID: 1361666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C and dopamine transport--1. Effects of amphetamine in vivo.
    Giambalvo CT
    Neuropharmacology; 1992 Dec; 31(12):1201-10. PubMed ID: 1361665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying the effects of amphetamine on particulate PKC activity.
    Giambalvo CT
    Synapse; 2004 Feb; 51(2):128-39. PubMed ID: 14618680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
    Giambalvo CT; Price LH
    Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogenetic effects of EEDQ on amphetamine-induced behaviors of rats: role of presynaptic processes.
    Crawford CA; McDougall SA; Bardo MT
    Psychopharmacology (Berl); 1994 Oct; 116(2):152-60. PubMed ID: 7862944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ.
    Tarazi FI; Kula NS; Zhang K; Baldessarini RJ
    Neuropharmacology; 2000 Aug; 39(11):2133-8. PubMed ID: 10963756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism.
    Park YH; Kantor L; Guptaroy B; Zhang M; Wang KK; Gnegy ME
    J Neurochem; 2003 Dec; 87(6):1546-57. PubMed ID: 14713310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C and dopamine release--III. Effect of dopamine depleting drugs.
    Giambalvo CT
    Biochem Pharmacol; 1989 Dec; 38(24):4445-54. PubMed ID: 2574975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M; McDougall SA
    Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
    Ekman A; Eriksson E
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA; McDougall SA; Bardo MT
    Neuropharmacology; 1994 Dec; 33(12):1559-65. PubMed ID: 7760979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S; Yokoo H; Nishi S
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
    Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.